Senseonics and TypeZero Sign Development Agreement for Artificial Pancreas and Decision Support Systems

Home - CBIC

GERMANTOWN, Md.--(BUSINESS WIRE)--

Senseonics Holdings, Inc. (SENS), a medical technology company focused on the development and commercialization of Eversense®, a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, and TypeZero Technologies, Inc., a personalized diabetes management company, today announced

Diffusion Pharmaceuticals Selects Contract Research Organization for Phase 3 Clinical Trial of Lead Compound TSC for Inoperable GBM Brain Cancer

Home - CBIC

Company Release - 7/31/2017 8:30 AM ET

CHARLOTTESVILLE, Va., July 31, 2017 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals, Inc. (NASDAQ:DFFN), a clinical stage biotechnology company developing novel small molecule therapeutics for cancer and other hypoxia-related diseases, announced today that it has selected a premier Clinical Research Organization (CRO)

VividCortex Raises $8.5m

Home - CBIC

VividCortex, the database performance management company that helps businesses improve application performance, reliability, and uptime, today announced that it has closed an $8.5 million Series A-1 round led by Osage Venture Partners (OVP). Bull City Venture Partners also participated in the round, as did all existing investors,

Charlottesville Women in Tech